Spots Global Cancer Trial Database for Procalcitonin Test for Differentiation of the Cause of Pneumonia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Procalcitonin Test for Differentiation of the Cause of Pneumonia
Official Title: Usefulness of Procalcitonin Test to Differentiate the Cause of Pneumonia in Patients With Cancers
Study ID: NCT03350802
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the usefulness of procalcitonin test for differentiation of the cause of pneumonia in patients with cancer.
Detailed Description: Serum procalcitonin test is currently used as the biomarker for bacterial infection. Especially, procalcitonin test has been reported to be helpful in differentiating bacterial pneumonia from viral pneumonia, acute exacerbations of interstitial pneumonitis or chronic obstructive lung disease. However, it is not known whether procalcitonin test can help distinguish bacterial pneumonia from non-bacterial pneumonia such as radiation pneumonitis or chemotherapy-induced pneumonitis in patients with cancer. The aim of this prospective cohort study is to observe the clinical benefits of procalcitonin test for differentiation of the cause of pneumonia in patients with cancer.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Respiratory Clinic, National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
Contact Details
Name: HEE SEOK LEE, M.D.
Affiliation: National Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
